Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease

OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) as well as the detection of anti-infliximab antibodies (ATIs) in patients with Crohn's disease (CD). METHOD: Forty patients with CD under treatment at a tertiary center in southeastern Brazil were...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Luis Eduardo Miani, da Silva, Francesca Aparecida Ramos, Pascoal, Lívia Bitencourt, Ricci, Renato Lazarin, Nogueira, Guilherme, Camargo, Michel Gardere, de Lourdes Setsuko Ayrizono, Maria, Fagundes, João José, Leal, Raquel Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445154/
https://www.ncbi.nlm.nih.gov/pubmed/30994711
http://dx.doi.org/10.6061/clinics/2019/e824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445154/
https://www.ncbi.nlm.nih.gov/pubmed/30994711
http://dx.doi.org/10.6061/clinics/2019/e824

Ejemplares similares